HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by López-Lázaro, M. Search for Related Content PubMed PubMed Citation Articles by López-Lázaro, M.

HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?

Department of Pharmacology, Faculty of Pharmacy, University of Seville, Seville, Spain

¹Correspondence: Department of Pharmacology, Faculty of Pharmacy, Seville, C/Professor Garcia Gonzalez, 41011, Sevilla, Spain. E-mail: mlopezlazaro{at}us.es

Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes involved in diverse aspects of cellular and integrative physiology, including energy metabolism, cell growth, survival, invasion, migration or angiogenesis. The activity of this transcription factor is known to be increased by hypoxia, but also by a growing number of apparently unrelated factors that can activate it even in nonhypoxic conditions. Here I propose a model in which an alteration in oxygen metabolism is the key cellular event involved in HIF-1 activation under hypoxic and nonhypoxic conditions. This new perspective unifies previously unrelated observations and predicts cellular processes and therapeutic strategies that may modify HIF-1 activity. This may have relevance, for instance, to cancer, as HIF-1 overexpression is observed in many human cancers and has been associated with increased patient mortality. López-Lázaro, M. HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?

Key Words: oxygen • ATP • glycolysis • hydrogen peroxide • cancer

This article has been cited by other articles:

				R. J. Gillies, I. Robey, and R. A. Gatenby Causes and Consequences of Increased Glucose Metabolism of Cancers J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S. [Abstract] [Full Text] [PDF]

				Q. Zhang, X. Tang, Z.-F. Zhang, R. Velikina, S. Shi, and A. D. Le Nicotine Induces Hypoxia-Inducible Factor-1{alpha} Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor Mediated Signaling Pathways Clin. Cancer Res., August 15, 2007; 13(16): 4686 - 4694. [Abstract] [Full Text] [PDF]

				M. Lopez-Lazaro Hypoxia-Inducible Factor 1 as a Possible Target for Cancer Chemoprevention Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2332 - 2335. [Abstract] [Full Text] [PDF]